Insight into Innate Immune Barriers Against AAV in the Human CNS

Time: 11:30 am
day: Day Two: Track B AM


  • Relevance of cell intrinsic innate immunity in AAV gene therapy
  • Innate immune sensing and signaling triggered by AAV in cells of the human CNS
  • How innate antiviral restriction factors may impact efficacy of AAV gene therapy